Researchers identified two compounds, procyanidin B2 and luteolin, from that showed better interaction with aromatase and higher stability than a commercial inhibitor. These compounds reduced aromatase concentration in ovarian tissues, indicating their potential as aromatase inhibitors for treating infertility in PCOS patients.
Researchers evaluated the potential of an ethanolic extract from the plant Roxb. to manage polycystic ovarian syndrome (PCOS) in a rat model. The extract showed beneficial effects in normalizing hormone levels and improving ovarian function. This suggests that the extract could be used as a treatment option for PCOS.